Skip to main content
SpringerLink
Log in

DHMA underscores limits for Pradaxa, Xarelto and Eliquis use

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. see Reactions 1434 p2; 803081761

Reference

  • Danish Health and Medicines Authority. Patients with mechanical heart valves should not be treated with the new oral anticoagulants Pradaxa, Xarelto and Eliquis. Danish Pharmacovigilance Update 4: 4-5, No. 11, 19 Dec 2014. Available from: URL: http://sundhedsstyrelsen.dk

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

DHMA underscores limits for Pradaxa, Xarelto and Eliquis use. Reactions Weekly 1492, 2 (2014). https://doi.org/10.1007/s40278-014-9308-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-9308-z

Search

Navigation